Trials / Completed
CompletedNCT00193674
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
Oral Dydrogesterone Treatment During the First Trimester of Pregnancy in Women With Recurrent Miscarriage: A Double-Blind, Prospectively Randomized, Placebo-Controlled, Parallel Group Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 71 (actual)
- Sponsor
- Abbott Products · Industry
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to demonstrate the shift from inflammatory cytokines to non-inflammatory cytokines in women suffering from habitual abortion treated with dydrogesterone (Duphaston).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dydrogesterone | 20 mg/day, oral |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2005-09-19
- Last updated
- 2011-08-26
Locations
3 sites across 2 countries: Austria, Poland
Source: ClinicalTrials.gov record NCT00193674. Inclusion in this directory is not an endorsement.